Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Multiple Myeloma × Gemcitabine × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 4 Urothelial Cancer 2 Urinary Bladder Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1 Non Small Cell Lung Cancer NSCLC 1 Nasopharyngeal Carcinoma 1 Metastatic Urothelial Cancer 1 Metastatic Adenocarcinoma of the Pancreas 1 Gallbladder Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma 1 Bile Duct Neoplasms 1

Interventions

Dexamethasone 16 daratumumab 9 Bortezomib 9 Lenalidomide 6 pomalidomide 4 carfilzomib 4 isatuximab 3 trametinib 2 selinexor 2 dabrafenib 2 Thalidomide 2 Prednisone 2 Melphalan 2 ulixertinib 1 trastuzumab biosimilar HLX02 1 talquetamab 1 sapanisertib 1 relatlimab 1 pertuzumab 1 palbociclib 1 osimertinib 1 omipalisib 1 montelukast 1 melflufen 1 larotrectinib 1 ipatasertib 1 idecabtagene vicleucel 1 erdafitinib 1 defactinib 1 darlin protein, Dictyostelium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡